and such patients develop the first innate immune response which, however, is not coupled with the secondary and antigen-specific adaptive immune response as they lack the machinery for gluten antigen presentation (26) .
CD diagnosis is currently based on genetical (HLA-DQ2+ and/or HLA-DQ8+) and serological markers (IgA anti-endomysial and/or IgA-tTG) coupled with duodenal histological alterations as assessed by duodenal endoscopy. Although the latter can be omitted in some cases like in first degree relatives of CD patients with both positive serology/genetics and clinically compatible symptoms, duodenal endoscopy is still the gold standard for CD diagnosis. Nevertheless, not all the patients agree with the need of a duodenal endoscopy especially those with silent or latent forms with no clinical symptomatology and/or those with non-CD gluten intolerance. The need of less invasive approaches for CD diagnosis is therefore a real need. Indeed, less invasive approaches would also allow an easier assessment of mucosal recovery after GFD allowing a better management of the disease.
In the current issue of Revista Española de Enfermedades Digestivas (The Spanish Journal of Gastroenterology), Bardellini et al. (27) present an interesting study addressing the question as to whether the oral mucosa could resemble the histopathological characteristics of the duodenal one in CD patients. In their cross-sectional study, they authors recruited a total of 18 CD patients at the moment of diagnosis (and therefore untreated), 19 CD patients following GFD for a variable amount to time and 15 healthy volunteers. Buccal biopsy specimens were obtained in all cases from normal looking mucosa for immunohistochemical characterization of T-cell subsets (CD3, CD4, CD8 and Tγδ). Duodenal samples were obtained from CD patients too. All untreated CD patients had a Marsh severity score over 3 (5) confirming CD diagnosis. The novelty of the work of Bardellini et al. (27) relies in the fact that they also described a dense inflammatory infiltrate rich in lymphoid cells with a considerable increase in Tγδ cells in the buccal mucosa from such untreated CD patients. GFD-treated patients displayed duodenal severity scores ranging from Marsh 0-2 (5), which was also mirrored by a slight increase of the buccal inflammatory infiltrate if compared with healthy controls but certainly lower than that reported in the untreated CD group. The findings from Bardellini et al. (27) in the buccal mucosa reflect therefore what has been shown to happen in the intestinal mucosa, where although GFD abolishes symptoms and normalizes serological markers, does not fully normalize in all CD patients in whom clinical remission is achieved (28) . Such findings have therefore great relevance for CD diagnosis and/or mucosal recovery assessment following GFD as the buccal mucosa provides a more accessible tissue to assess the duodenal status.
The findings from Bardellini et al. (27) and other similar observations (29) are however opposed to other recent studies (30, 31) which found no differences regarding oral mucosa lymphocyte infiltrate in CD patients when compared with healthy controls. Therefore, more studies similar to the one by Bardellini et al. (27) should be performed including larger multi-center cohorts and a blinded comparison of the duodenal and buccal immunohistochemistry analysis to confirm their findings. Other studies should also address the mechanisms controlling the lymphocyte infiltrate at the buccal mucosa. Is the buccal mucosa responding to the ingested gluten or it is mirroring the duodenum? If the latter, what is the mechanism controlling that? Are the buccal lymphocyte infiltrates gluten specific? Are there other cell infiltrates like DC? Some of such intriguing questions could be answered via DC and/or T-cell subset characterization of the buccal biopsies (flow cytometry, immunohistochemistry…) and/or immune mediators (ELISA, Western-blot…) production of the buccal explants both in freshly obtained biopsies and after in vitro gluten/gliadin challenge from CD (treated/untreated) patients and non-CD controls. Also, it cannot be discarded that the buccal infiltrates may be a consequence of altered leukocyte trafficking in CD patients (32) , which could be reflected in altered homing profile of circulating leukocyte as recently reported in CD patients even on the GFD (33) . Finally, the findings from Bardellini et al. (27) may also have implication to study the pathogenesis and/or diagnosis of non-CD gluten intolerance patients as it would also be very interesting to study if such group of patients also display such "Marsh-like" lesion at the buccal mucosa which would throw some light into the, still evasive, mechanisms controlling non-CD gluten intolerance. 
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